{
  "id": 3733850,
  "title": "Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights",
  "url": "https://urgent.news/2026/08/27/conavi-medical-reports-fiscal-third-quarter-2026-results-and",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-27T12:06:41.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/conavi-medical-reports-fiscal-third-quarter-2026-results-and-operational-highlights"
  },
  "original_language": "en",
  "account": null,
  "summary": "Net loss for Fiscal Q3 2026 was $6.3 million (Fiscal Q3 2025 – $3.6 million) reflecting continued investment in research and development activities of $4.4 million (Fiscal Q3 2025 – $3.2 million) Ended Fiscal Q3 2026 with $0.9M in cash and cash equivalents (Fiscal Q4 2025 – $5.8 million) and on August 12, 2026 closed […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}